Rho Capital Partners’s NEPHROGENEX INC COM NRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-1,052,966
Closed -$495K 9
2016
Q1
$495K Hold
1,052,966
0.27% 9
2015
Q4
$1.69M Hold
1,052,966
0.58% 8
2015
Q3
$3.56M Hold
1,052,966
1.18% 8
2015
Q2
$6.99M Hold
1,052,966
2.44% 8
2015
Q1
$8.29M Sell
1,052,966
-273,860
-21% -$2.15M 3.46% 6
2014
Q4
$17.7M Hold
1,326,826
7.86% 5
2014
Q3
$6.21M Hold
1,326,826
3.12% 6
2014
Q2
$8.07M Hold
1,326,826
3.13% 6
2014
Q1
$10.8M Buy
+1,326,826
New +$13.5M 4.2% 6

Rho Capital Partners's NRX Position: Q2 2016 in Review

Rho Capital Partners sold out of NEPHROGENEX INC COM (NRX) in Q2 2016, closing a stake of 1,052,966 shares — an estimated $495K sold.

Rho Capital Partners first reported a position in NRX in Q1 2014 and held it in 9 quarters. The position peaked at $17.7M in Q4 2014. 1 fund tracked by Wall St. Rank holds NRX as of Q2 2016.

  • Rho Capital Partners reported no remaining NEPHROGENEX INC COM position as of Q2 2016 after selling out during the quarter.
  • Rho Capital Partners sold 1,052,966 NEPHROGENEX INC COM shares in Q2 2016, an estimated $495K.
  • Rho Capital Partners first reported a position in NEPHROGENEX INC COM in Q1 2014 and held it in 9 quarters.
  • Rho Capital Partners's NEPHROGENEX INC COM position peaked at $17.7M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held NEPHROGENEX INC COM as of Q2 2016.

Based on Rho Capital Partners's 13F filing for Q2 2016, filed 13 Jul 2016.